Literature DB >> 27109937

Association between microRNA polymorphisms and the risk of inflammatory bowel disease.

Min Zhu1, Diangeng Li2, Meiling Jin2, Mingyang Li3.   

Abstract

Common single nucleotide polymorphisms (SNPs) in precursor microRNAs may change their properties via altering the expression of miRNAs, resulting in diverse functional consequences. The present study evaluated the effects of four common SNPs in pro-miRNAs on the risk of inflammatory bowel disease (IBD) and IBD‑associated colorectal cancer (IBD-CRC). In a hospital based case‑control investigation in a Chinese population, 468 patients with IBD and 450 age- and gender-matched healthy subjects were enrolled in the present study. The SNPs were genotyped using a polymerase chain reaction (PCR)-restriction fragment length polymorphism technique. The expression levels of the miRNAs were detected by reverse transcription‑PCR. For rs2910164, the risk of IBD was significantly increased in the GC and CC genotypes. The mean expression levels of mir‑146a in the CC and GC genotypes were lower, compared with that of the GG genotype. For rs2292832, an increased risk of IBD was detected in the recessive model of the TT genotype, compared with the combination of the CT and CC genotypes. The [T] allele was found to be at increased significantly, with a 1.268‑fold increased risk of IBD, compared with the [C] allele. The mean expression levele of mir‑149 expression level in the TT genotype was lower, compared with that of the CC genotype. For rs11614913, the risk of IBD‑CRC was significantly increased in the CC genotype, compared with the TT genotype. In the dominant model, the CC genotype had a high risk of IBD‑CRC, compared with the combination of the CT and TT genotypes. These findings suggested that mir-146a rs2910164 and mir‑149 rs2292832 may be associated with the increased risk of IBD via alterations in the expression levels of miRNAs. Therefore, mir‑196a rs11614913 may contribute to the progression of IBD-CRC.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27109937     DOI: 10.3892/mmr.2016.5157

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  11 in total

1.  Polymorphisms in MIR122, MIR196A2, and MIR124A Genes are Associated with Clinical Phenotypes in Inflammatory Bowel Diseases.

Authors:  Cinzia Ciccacci; Cristina Politi; Livia Biancone; Andrea Latini; Giuseppe Novelli; Emma Calabrese; Paola Borgiani
Journal:  Mol Diagn Ther       Date:  2017-02       Impact factor: 4.074

2.  miRNA-133a-UCP2 pathway regulates inflammatory bowel disease progress by influencing inflammation, oxidative stress and energy metabolism.

Authors:  Xi Jin; Dong Chen; Ruo-Heng Zheng; Hong Zhang; Yi-Peng Chen; Zun Xiang
Journal:  World J Gastroenterol       Date:  2017-01-07       Impact factor: 5.742

3.  MicroRNA-146a regulates immune-related adverse events caused by immune checkpoint inhibitors.

Authors:  Dominik Marschner; Martina Falk; Nora Rebeka Javorniczky; Kathrin Hanke-Müller; Justyna Rawluk; Annette Schmitt-Graeff; Federico Simonetta; Eileen Haring; Severin Dicks; Manching Ku; Sandra Duquesne; Konrad Aumann; David Rafei-Shamsabadi; Frank Meiss; Patrick Marschner; Melanie Boerries; Robert S Negrin; Justus Duyster; Robert Zeiser; Natalie Köhler
Journal:  JCI Insight       Date:  2020-03-26

Review 4.  Association of Three Polymorphisms rs11614913, rs2910146, and rs3746444 in miRNA-196a2, miRNA-146a, and miRNA-499 with Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis.

Authors:  Ying Liu; Lingxin Xiong; Yan Zhou; Bingzhen Zheng; Tongjun Liu; Wei Xie
Journal:  Gastroenterol Res Pract       Date:  2018-03-07       Impact factor: 2.260

5.  Meta-Analysis of miRNA Variants Associated with Susceptibility to Autoimmune Disease.

Authors:  Jun Zhang; Handan Tan; Qingfeng Cao; Guannan Su; Peizeng Yang
Journal:  Dis Markers       Date:  2021-10-08       Impact factor: 3.434

6.  Investigating the association of rs2910164 with cancer predisposition in an Irish cohort.

Authors:  T P McVeigh; R J Mulligan; U M McVeigh; P W Owens; N Miller; M Bell; F Sebag; C Guerin; D S Quill; J B Weidhaas; M J Kerin; A J Lowery
Journal:  Endocr Connect       Date:  2017-09-12       Impact factor: 3.335

7.  Association of miR-146 rs2910164, miR-196a rs11614913, miR-221 rs113054794 and miR-224 rs188519172 polymorphisms with anti-TNF treatment response in a Greek population with Crohn's disease.

Authors:  Ioannis Papaconstantinou; Christina Kapizioni; Evangelia Legaki; Elena Xourgia; George Karamanolis; Antonios Gklavas; Maria Gazouli
Journal:  World J Gastrointest Pharmacol Ther       Date:  2017-11-06

Review 8.  Association of miRNA-146a rs2910164 and miRNA-196 rs11614913 polymorphisms in patients with ulcerative colitis: A meta-analysis and review.

Authors:  Zhongyi Li; Yao Wang; Yi Zhu
Journal:  Medicine (Baltimore)       Date:  2018-09       Impact factor: 1.889

9.  Profiling the lncRNA-miRNA-mRNA ceRNA network to reveal potential crosstalk between inflammatory bowel disease and colorectal cancer.

Authors:  Fangfang Sun; Weiwei Liang; Kejun Tang; Mengying Hong; Jing Qian
Journal:  PeerJ       Date:  2019-08-26       Impact factor: 2.984

10.  Association between the miRNA-149 rs2292832 T>C polymorphism and Kawasaki disease susceptibility in a southern Chinese population.

Authors:  Jiawen Li; Jinxin Wang; Xiaoping Su; Zhiyong Jiang; Xing Rong; Xueping Gu; Chang Jia; Lanlan Zeng; Hao Zheng; Xiaoqiong Gu; Maoping Chu
Journal:  J Clin Lab Anal       Date:  2019-11-29       Impact factor: 2.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.